All Publications

  1. Davies MR, Garcia S, Tamaki S, Liu X, Lee S, Jose A, Pomerantz JH, Feeley BT. Muscle Stem Cell Activation in a Mouse Model of Rotator Cuff Injury. J Orthop Res. 2017 Aug 08. View in PubMed
  2. Cho GJ, Wang F, Garcia SM, Viner J, Hoffman WY, McDermott MW, Pomerantz JH. Recalcitrant Invasive Skin Cancer of the Scalp: Combined Extirpation and Microsurgical Reconstruction Without Cranioplasty. J Craniofac Surg. 2017 Mar; 28(2):325-330. View in PubMed
  3. Niethamer TK, Larson AR, O'Neill AK, Bershteyn M, Hsiao EC, Klein OD, Pomerantz JH, Bush JO. EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells. Stem Cell Reports. 2017 Mar 14; 8(3):529-537. View in PubMed
  4. Garcia SM, Tamaki S, Xu X, Pomerantz JH. Human Satellite Cell Isolation and Xenotransplantation. Methods Mol Biol. 2017; 1668:105-123. View in PubMed
  5. Hesse RG, Kouklis GK, Ahituv N, Pomerantz JH. The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. Elife. 2015 Nov 17; 4. View in PubMed
  6. Xu X, Wilschut KJ, Kouklis G, Tian H, Hesse R, Garland C, Sbitany H, Hansen S, Seth R, Knott PD, Hoffman WY, Pomerantz JH. Human Satellite Cell Transplantation and Regeneration from Diverse Skeletal Muscles. Stem Cell Reports. 2015 Sep 08; 5(3):419-34. View in PubMed
  7. Balkin DM, Chen I, Oberoi S, Pomerantz JH. Bilateral Coronoidectomy by Craniofacial Approach for Hecht Syndrome-Related Trismus. J Craniofac Surg. 2015 Sep; 26(6):1954-6. View in PubMed
  8. Tamaki S, Nye C, Slorach E, Scharp D, Blau HM, Whiteley PE, Pomerantz JH. Simultaneous silencing of multiple RB and p53 pathway members induces cell cycle reentry in intact human pancreatic islets. BMC Biotechnol. 2014 Oct 11; 14:86. View in PubMed
  9. Pomerantz JH, Blau HM. Tumor suppressors: enhancers or suppressors of regeneration? Development. 2013 Jun; 140(12):2502-12. View in PubMed
  10. Garland CB, Pomerantz JH. Regenerative strategies for craniofacial disorders. Front Physiol. 2012; 3:453. View in PubMed
  11. Blau HM, Pomerantz JH. Re"evolutionary" regenerative medicine. JAMA. 2011 Jan 05; 305(1):87-8. View in PubMed
  12. Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell. 2010 Dec 23; 143(7):1059-71. View in PubMed
  13. Pajcini KV, Corbel SY, Sage J, Pomerantz JH, Blau HM. Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell. 2010 Aug 06; 7(2):198-213. View in PubMed
  14. Pomerantz JH, Mukherjee S, Palermo AT, Blau HM. Reprogramming to a muscle fate by fusion recapitulates differentiation. J Cell Sci. 2009 Apr 01; 122(Pt 7):1045-53. View in PubMed
  15. Palermo A, Doyonnas R, Bhutani N, Pomerantz J, Alkan O, Blau HM. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J. 2009 May; 23(5):1431-40. View in PubMed
  16. Pajcini KV, Pomerantz JH, Alkan O, Doyonnas R, Blau HM. Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. J Cell Biol. 2008 Mar 10; 180(5):1005-19. View in PubMed
  17. Gruber RP, Weintraub J, Pomerantz J. Suture techniques for the nasal tip. Aesthet Surg J. 2008 Jan-Feb; 28(1):92-100. View in PubMed
  18. Wan DC, Pomerantz JH, Brunet LJ, Kim JB, Chou YF, Wu BM, Harland R, Blau HM, Longaker MT. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem. 2007 Sep 07; 282(36):26450-9. View in PubMed
  19. Zhang F, Pomerantz JH, Sen G, Palermo AT, Blau HM. Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proc Natl Acad Sci U S A. 2007 Mar 13; 104(11):4395-400. View in PubMed
  20. Wehrman TS, Raab WJ, Casipit CL, Doyonnas R, Pomerantz JH, Blau HM. A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19063-8. View in PubMed
  21. Palermo AT, Labarge MA, Doyonnas R, Pomerantz J, Blau HM. Bone marrow contribution to skeletal muscle: a physiological response to stress. Dev Biol. 2005 Mar 15; 279(2):336-44. View in PubMed
  22. Pomerantz J, Blau HM. Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nat Cell Biol. 2004 Sep; 6(9):810-6. View in PubMed
  23. Orlow I, Rabbani F, Chin L, Pomerantz J, Ligeois N, Dudas M, Depinho R, Cordón-Cardó C. Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis. Int J Oncol. 1999 Jul; 15(1):17-24. View in PubMed
  24. Chin L, Pomerantz J, DePinho RA. The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci. 1998 Aug; 23(8):291-6. View in PubMed
  25. Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 1998 Mar 20; 92(6):713-23. View in PubMed
  26. Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner JW, DePinho RA. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 1997 Nov 01; 11(21):2822-34. View in PubMed
  27. Feldherr CM, Pomerantz J. Mechanism for the selection of nuclear polypeptides in Xenopus oocytes. J Cell Biol. 1978 Jul; 78(1):168-75. View in PubMed
Data provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Jason H. Pomerantz, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.